Advanced search
Publication Cover
OncoImmunology Volume 11, 2022 - Issue 1
Submit an article Journal homepage
2,380
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients

Martine Bloemendala Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences; Radboud University Medical Center, Nijmegen, the Netherlands;b Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the NetherlandsView further author information
,
Kalijn F. Bola Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences; Radboud University Medical Center, Nijmegen, the Netherlands;b Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the NetherlandsORCID Iconhttps://orcid.org/0000-0003-4165-2040View further author information
ORCID Icon,
Steve Boudewijnsa Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences; Radboud University Medical Center, Nijmegen, the Netherlands;b Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the NetherlandsView further author information
,
Mark A.J. Gorrisa Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences; Radboud University Medical Center, Nijmegen, the NetherlandsORCID Iconhttps://orcid.org/0000-0003-3621-226XView further author information
ORCID Icon,
Johannes H.W. de Wiltc Department of Surgery, Radboud University Medical Center, Nijmegen, the NetherlandsView further author information
,
Sandra A.J. Croockewitd Department of Hematology, Radboud University Medical Center, Nijmegen, the NetherlandsView further author information
,
Michelle M. van Rossume Department of Dermatology, Radboud University Medical Center, Nijmegen, the NetherlandsView further author information
,
Anna L. de Goedef Department of Pharmacy, Radboud University Medical Center, Nijmegen, the NetherlandsView further author information
,
Katja Petryg Miltenyi Biotec GmbH, Bergisch Gladbach, GermanyView further author information
,
Rutger H.T. Koornstrah Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the NetherlandsView further author information
,
Carl Figdora Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences; Radboud University Medical Center, Nijmegen, the Netherlands;i Oncode Institute, Utrecht, the NetherlandsView further author information
,
Winald R. Gerritsenb Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the NetherlandsView further author information
,
Gerty Schreibelta Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences; Radboud University Medical Center, Nijmegen, the NetherlandsView further author information
&
I. Jolanda M. de Vriesa Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences; Radboud University Medical Center, Nijmegen, the NetherlandsCorrespondence[email protected]
View further author information
 show all
Article: 2015113 | Received 25 May 2021, Accepted 02 Dec 2021, Published online: 30 Dec 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.